TrialFrontiers in medicine2025

Efficacy and safety of intradermal botulinum toxin A for post-acne erythema: a split-face randomized controlled trial.

Li Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.